CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for IXICO plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

IXICO plc
4th Fl, Griffin Court, 15 Long Lane
Phone: +44 2037637499p:+44 2037637499 LONDON, EC1A 9PN  United Kingdom Ticker: IXIIXI
Business Summary
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20259/30/2024YesYes---

Industries
SIC Code Description
6719 Offices of holding companies, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Mark R.Warne 47 1/25/2024 9/16/2016
Chief Executive Officer BramGoorden 50 8/19/2024 8/19/2024
Chief Financial Officer, Executive Director, Company Secretary Grant R.Nash 46 5/31/2019 4/29/2019
Non-Executive Director Katherine J.Rogers 57 1/21/2022 1/21/2022
Non-Executive Independent Director DiptiAmin 61 10/5/2023 10/5/2023

Business Names
Business Name
A1W23U
IXI
IXICO PLC
8 additional Business Names available in full report.

General Information
Number of Employees: 81 (As of 9/30/2024)
Outstanding Shares: 92,668,598 (As of 3/31/2025)
Shareholders: 2,529
Stock Exchange: LON
Fax Number: +44 2072092473


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, August 22, 2025